- Investing Ideas
- /
- French Pharmaceuticals & Biotech Top Stock Picks from Analysts
French Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
18
Companies which are more than 50% undervalued based on analyst price target.
18 companies
Valneva
Market Cap: €648.8m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
VLA
€3.78
7D
-1.7%
1Y
77.0%
Inventiva
Market Cap: €479.4m
A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.
IVA
€3.45
7D
5.7%
1Y
32.5%
Cellectis
Market Cap: €258.6m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€3.58
7D
9.2%
1Y
100.8%
Genfit
Market Cap: €188.2m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.78
7D
3.0%
1Y
-8.9%
Transgene
Market Cap: €170.8m
A biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France.
TNG
€1.29
7D
4.5%
1Y
66.2%
Adocia
Market Cap: €154.5m
A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
ADOC
€8.47
7D
-4.6%
1Y
0.8%
ABIONYX Pharma
Market Cap: €146.0m
A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
ABNX
€4.21
7D
-1.6%
1Y
218.9%
Innate Pharma
Market Cap: €142.9m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.55
7D
-9.4%
1Y
5.4%
OSE Immunotherapeutics
Market Cap: €121.4m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.42
7D
-4.6%
1Y
-40.3%
Sensorion
Market Cap: €101.6m
A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.
ALSEN
€0.34
7D
-0.3%
1Y
-50.3%
AB Science
Market Cap: €83.7m
A clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.
AB
€1.15
7D
-2.7%
1Y
33.3%
MaaT Pharma
Market Cap: €67.6m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€4.20
7D
10.5%
1Y
-49.4%
Nicox
Market Cap: €26.1m
Operates as an ophthalmology company in France and internationally.
ALCOX
€0.32
7D
-2.4%
1Y
44.4%
Advicenne
Market Cap: €22.5m
A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.
ALDVI
€1.59
7D
-8.0%
1Y
-25.2%
Valbiotis
Market Cap: €21.5m
Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.
ALVAL
€0.91
7D
51.7%
1Y
-24.9%
GenSight Biologics
Market Cap: €17.4m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
SIGHT
€0.10
7D
-21.1%
1Y
-68.7%
Aelis Farma
Market Cap: €14.9m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.10
7D
-3.1%
1Y
-60.9%
Oncodesign Precision Medicine Société anonyme
Market Cap: €8.4m
A biopharmaceutical company, engages in the precision medicine business.
ALOPM
€0.46
7D
-8.7%
1Y
-56.6%